CALP: Summary for Caliper Life Sciences Inc - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 8:22am EST - Canadian Markets open in 1 hour and 8 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Caliper Life Sciences, Inc. (CALP)

On Feb 9: 3.15 USD 0.00 (0.00%)

MORE ON CALP

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Caliper Life Sciences Inc (NGM:CALP) Delayed quote data

Last Trade:	3.15 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	3.15
Open:	N/A
Bid:	0.01 x 200
Ask:	2,000.00 x 200
1y Target Est:	3.00

Day's Range:	N/A - N/A
52wk Range:	0.76 - 3.60
Volume:	0
Avg Vol (3m):	64,336.5
Market Cap:	154.45M
P/E (ttm):	N/A
EPS (ttm):	-1.24
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CALP to Portfolio

Download Data

HEADLINES

•	RBC Capital Markets Expert Equity Analyst Sees "Shopping Spree" For Acquisitions Of Home Health Care And Diagnostics Companies In 2010 To 2011 Time Frame
	Wall Street Transcript (Wed, Feb 3)

•	Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
	PRNewswire (Mon, Jan 25)

•	Caliper Integrated Robotic System Featured in TIME Magazine's Top 10 Scientific Discoveries of 2009
	PRNewswire (Thu, Jan 21)

•	LaBranche, Caliper Life Sciences: Biggest Price Gainers (LAB, CALP)
	at The Wall Street Journal Online (Thu, Jan 14)

•	[$$] Waiting On Intel
	at RealMoney by TheStreet.com (Thu, Jan 14)

•	CALIPER LIFE SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure
	EDGAR Online (Thu, Jan 14)

•	Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2009
	PRNewswire (Thu, Jan 14)

•	Caliper Licenses Microfluidics IP to Becton Dickinson
	PRNewswire (Mon, Jan 11)

•	Caliper Life Sciences to Present at the 28th Annual J.P. Morgan Healthcare Conference
	PRNewswire (Tue, Jan 5)

•	CALIPER LIFE SCIENCES INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off
	EDGAR Online (Thu, Dec 17)

More Headlines for CALP...

ANALYST

EPS Est (next year) (Dec-09) :	-0.18
EPS Est (in 2 years) (Dec-10) :	-0.11
Avg Rec (current)*:	1.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.

Full Company Profile

Add to Portfolio

Email to a Friend

•